47 studies found for:    Open Studies | MRSA
Show Display Options
Rank Status Study
21 Not yet recruiting Impact of Rapid Detection of MRSA
Condition: Staphylococcus Aureus Infections
Intervention:
22 Recruiting Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia
Condition: Bacteremia Due to Staphylococcus Aureus
Interventions: Drug: Daptomycin;   Drug: Vancomycin
23 Not yet recruiting New Mexico Honey Wound Treatment Research Study
Condition: Community-acquired MRSA Infection
Interventions: Drug: New Mexico Honey;   Drug: Bactrim DS
24 Unknown  A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
Condition: Infection
Interventions: Dietary Supplement: Lactobacillus rhamnosus;   Dietary Supplement: Sugar pill (placebo)
25 Unknown  Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns
Condition: Staphylococcus Aureus Infection
Intervention: Other: CA-MRSA Decolonization
26 Recruiting Study of 2% Chlorhexidine Gluconate-Impregnated Bath Cloths to Prevent MRSA Colonization in Complex Continuing Care
Condition: Staph Aureus Methicillin Resistant Colonization
Intervention: Drug: CHG antiseptic body cleanser
27 Unknown  Relationship of Staphylococcal Colonization to Infection
Condition: MRSA Infection
Intervention:
28 Not yet recruiting Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) Carriers
Conditions: Resistant Staphylococcus Aureus: [Methicillin] or [Multiple];   Cholecalciferol Toxicity;   Staphylococcus Aureus Infections
Interventions: Drug: Cholecalciferol;   Other: Placebo
29 Recruiting A Phase III Study to Evaluate the Efficacy and Safety of BAY 1192631 in Japanese Patients With MRSA Infections (SSTI and SSTI-related Bacteremia).
Condition: Skin Diseases, Infectious
Interventions: Drug: Tedizolid(BAY1192631);   Drug: Linezolid
30 Unknown  Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community
Conditions: ESBL Infection;   Methicillin-Resistant Staphylococcus Aureus
Intervention:
31 Recruiting Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Condition: Staph Aureus Methicillin Resistant Bacteremia
Interventions: Drug: Fosfomycin 2gr/6h iv;   Drug: Daptomycin 10mg/kg/24h iv
32 Unknown  Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial
Conditions: Hospital-Acquired Infection With Clostridium Difficile;   Hospital-Acquired VRE Infection or Colonization;   Hospital-Acquired MRSA Infection or Colonization
Intervention: Other: Admission to a novel hospital ward
33 Recruiting Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Condition: Cystic Fibrosis
Interventions: Drug: Inhaled Vancomycin;   Drug: Placebo (Sterile Water);   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);   Drug: Doxycycline;   Drug: Mupirocin Nasal Ointment;   Drug: 4% chlorhexidine gluconate liquid skin cleanser
34 Recruiting Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Condition: Staphylococcal Infection
Interventions: Drug: Clindamycin;   Drug: Placebo;   Drug: Trimethoprim-sulfamethoxazole (TS)
35 Recruiting Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia
Condition: Pneumonia
Intervention: Drug: Linezolid
36 Unknown  Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.
Condition: Wound Infection
Intervention: Drug: Vancomycin
37 Unknown  Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
Conditions: Methicillin-Resistant Staphylococcus Aureus;   ESBL
Intervention:
38 Recruiting The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?
Condition: Methicillin-resistant Staphylococcus Aureus Septicemia
Intervention:
39 Recruiting Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Conditions: Bacterial Infection;   Malignant Neoplasm;   Methicillin-resistant Staphylococcus Aureus Infection;   Nonmalignant Neoplasm
Interventions: Drug: chlorhexidine gluconate;   Procedure: wound care management;   Other: questionnaire administration
40 Recruiting Experimental Phage Therapy of Bacterial Infections
Condition: Bacterial Infections
Intervention: Other: Bacteriophage preparation

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results
Indicates status has not been verified in more than two years